Wealthquest Corp Purchases Shares of 13,516 Amedisys, Inc. (NASDAQ:AMED)

Wealthquest Corp purchased a new stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 13,516 shares of the health services provider's stock, valued at approximately $1,310,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. MassMutual Private Wealth & Trust FSB raised its position in shares of Amedisys by 56.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 334 shares of the health services provider's stock valued at $31,000 after purchasing an additional 120 shares during the period. Fifth Third Bancorp increased its holdings in Amedisys by 68.1% during the 1st quarter. Fifth Third Bancorp now owns 348 shares of the health services provider's stock worth $32,000 after acquiring an additional 141 shares during the period. Blue Trust Inc. increased its holdings in Amedisys by 55.1% during the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after acquiring an additional 124 shares during the period. UMB Bank n.a. increased its holdings in Amedisys by 100.0% during the 1st quarter. UMB Bank n.a. now owns 386 shares of the health services provider's stock worth $36,000 after acquiring an additional 193 shares during the period. Finally, Johnson Financial Group Inc. bought a new stake in Amedisys during the 4th quarter worth approximately $55,000. Institutional investors own 94.36% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $100.00 target price on shares of Amedisys in a report on Wednesday, April 16th. Wall Street Zen lowered shares of Amedisys from a "strong-buy" rating to a "buy" rating in a report on Saturday, May 24th. Finally, Stephens reaffirmed an "equal weight" rating and set a $101.00 target price on shares of Amedisys in a report on Tuesday, March 4th. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, Amedisys has a consensus rating of "Hold" and a consensus price target of $100.75.

Amedisys Price Performance

AMED stock traded down $0.11 during midday trading on Friday, reaching $97.92. The company had a trading volume of 397,167 shares, compared to its average volume of 420,408. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.29 and a quick ratio of 1.29. Amedisys, Inc. has a 1 year low of $82.15 and a 1 year high of $98.95. The company has a market capitalization of $3.21 billion, a P/E ratio of 36.13, a P/E/G ratio of 1.33 and a beta of 0.94. The firm has a 50-day moving average price of $95.28 and a 200-day moving average price of $92.60.

Amedisys (NASDAQ:AMED - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The health services provider reported $1.25 EPS for the quarter, topping analysts' consensus estimates of $1.13 by $0.12. Amedisys had a net margin of 3.79% and a return on equity of 12.52%. The business had revenue of $594.78 million during the quarter, compared to analysts' expectations of $597.43 million. During the same quarter in the previous year, the company earned $1.03 EPS. The business's quarterly revenue was up 4.1% compared to the same quarter last year. On average, research analysts anticipate that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.